Evidence map›Paper›PMID 41599863›Full record

Trial reportNutrients2026

Efficacy and Safety of CKDB-322, a Combination of

Hyang-Im Baek, So-Young Kwon, Hye-Ji Noh, Soo Jung Park

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hyang-Im BaekDepartment of Food Science & Nutrition, Woosuk University, Wanju 55338, Republic of Korea.ORCID 0000-0002-2829-4499
So-Young KwonResearch Institute, Chong Kun Dang Bio (CKD Bio), Seoul 03742, Republic of Korea.ORCID 0009-0001-7430-2402
Hye-Ji NohResearch Institute, Chong Kun Dang Bio (CKD Bio), Seoul 03742, Republic of Korea.ORCID 0000-0002-9065-263X
Soo Jung ParkDepartment of Sasang Constitutional Medicine, College of Korean Medicine, Woosuk University, Jeonju 55338, Republic of Korea.ORCID 0000-0001-8191-4290

Funding

Ministry of Education 2025-RISE-13-WSUMinistry of Trade, Industry and Energy 20020268
6 · The paper itself

Abstract

backgroundCKDB-322, a combination of

methodsParticipants were aged 19-65 years; had a body mass index (BMI) of 25-30 kg/m

resultsCKDB-322 supplementation resulted in statistically significant reductions in body fat mass and body fat percentage, as measured by dual-energy X-ray absorptiometry (DEXA), compared to the placebo group (

conclusionsCollectively, CKDB-322 demonstrated a favorable safety profile and produced statistically significant improvements in multiple adiposity-related outcomes, including reductions in body fat mass, abdominal adiposity, and key anthropometric measures, supporting its potential as a functional ingredient for body fat reduction and metabolic health.

Indexed as

Abdominal FatAdiposityDiatomsLactiplantibacillus plantarumObesity, AbdominalOverweightProbioticsAdipose TissueAdultAgedBody Mass IndexDouble-Blind MethodFemaleHumansMaleMiddle Agedabdominal fatanti-obesitybody fatLactiplantibacillus plantarummetabolic healthmicroalgaeoverweightPhaeodactylum tricornutumprobiotics

Identifiers

PMID41599863
PMCPMC12845410

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.